The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from CNW Group

BIOREM receives first orders for its biogas sweetening systems

Wednesday, June 02, 2010

BIOREM receives first orders for its biogas sweetening systems07:00 EDT Wednesday, June 02, 2010GUELPH, ON, June 2 /CNW/ - BIOREM Inc. (TSX-V: BRM) today announced that it has received two orders for biogas sweetening systems in North America. The sweetening systems will use Biorem's proprietary low energy biological technologies to remove high levels of hydrogen sulfide (H2S) from raw biogas, enhancing its value for use in renewable energy generation. One of the systems will purify biogas captured from a landfill site while the other will purify biogas generated from the anaerobic digesters of a municipal wastewater treatment facility. The biogas sweetening systems will be installed and operating this year."These orders highlight the progress of Biorem's expansion into the renewable energy market and showcase the potential for our proprietary biological-based systems to significantly enhance biogas recovery," said Peter Bruijns, President and CEO. "While biogas can be generated from a variety of sources, it often contains impurities which must be removed. Using energy intensive solutions or chemical processes to purify biogas counteracts the value of biogas as a renewable energy source. As such, we expect our low-energy biologically-based systems will become recognized as an essential and economical component in biogas generation."As previously announced, in addition to its established leadership position in the odor control market, Biorem is concentrating on two new major market segments: renewable energy (biogas purification) and treating emissions of volatile organic compounds (VOC). These two combined markets are estimated to be $425 million annually in North America, and will also provide significant opportunities in China where Biorem also operates.About BIOREM Inc.Biorem is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network and over 600 installed systems worldwide, Biorem not only offers state-of-the-art technology-based products but also peace of mind for municipalities, industrial companies and their surrounding communities. Additional information on Biorem is available on our website at www.biorem.biz.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Forward-Looking StatementsThis press release contains forward-looking statements based on current expectations. These forward-looking statements contain various risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Risks and uncertainties about the Company's business are more fully discussed in the disclosure materials, financial statements and MD&A filed with the securities regulatory authorities in Canada on www.sedar.comNon-GAAP Measures"Bookings" and "Backlog" do not have any standardized meaning prescribed by Canadian generally accepted accounting principles ("GAAP") and may not be comparable to measures presented by other companies. Bookings and Backlog are non-GAAP measures that the Company uses to evaluate its sales performance. Bookings are those binding contracts that the Company enters into with a third party for the delivery of our products or services. As Bookings are received, the contract value (before any associated sales taxes) is included in the Backlog. The Backlog is reduced by the revenue that is recognized on each project and then adjusted for any currency changes.%SEDAR: 00020304EFor further information: Ed Corbett, Chief Financial Officer, BIOREM Technologies Inc., ecorbett@biorem.biz, Tel: (519) 767-9100 x275; James Smith, Investor Relations, The Equicom Group Inc., jsmith@equicomgroup.com, Tel: (416) 815-0700 x229